The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

The global Rare Disease Genetic Testing Market size was valued at USD 1.3 billion in 2025 and is projected to grow from USD 1.5 billion in 2026 to USD 3.9 billion by 2033, registering a CAGR of 14.9% from 2026 to 2033. North America accounted for the largest revenue share of 46.7% in 2025, supported by advanced genomic research, widespread adoption of next-generation sequencing (NGS),...

The Base Editing Market is redefining the future of genomic medicine by enabling highly accurate DNA modifications with minimal risk of unintended genetic damage. Unlike traditional gene-editing technologies, base editing allows precise alteration of individual DNA bases without creating double-strand breaks. This capability significantly enhances safety and efficiency, making base editing a...

The increasing prevalence of cardiovascular disorders, diabetes, obesity, and metabolic syndromes is significantly driving the growth of the cardiometabolic diseases market worldwide. Rising healthcare expenditure, growing awareness regarding chronic disease management, and advancements in pharmaceutical therapies are contributing to the expansion of the industry. Healthcare providers and...

Clinical genetic testing adoption across China's extensive hospital network is approaching what many industry observers characterize as an inflection point in 2026, as oncology genomic profiling, reproductive genetic testing, rare disease genetic diagnosis, and pharmacogenomic testing transition from specialized academic medical center services to mainstream clinical tools deployed across...

The North America CRISPR and Cas Gene is witnessing robust growth owing to increasing investments in biotechnology research, expanding applications of gene-editing technologies, and supportive regulatory initiatives. The region benefits from well-established healthcare infrastructure, high research and development spending, and strong collaboration among pharmaceutical companies, research...

The North America PARP inhibitor biomarkers testing product market is experiencing significant expansion due to growing awareness of personalized medicine, increasing cancer incidence, and rapid advancements in molecular diagnostics. The region benefits from a well-established healthcare ecosystem, strong government support for cancer research, and widespread access to genomic testing...

As of February 2026, the global animal health landscape is undergoing a structural transformation, with the Veterinary Medicine Market evolving from traditional reactive treatments toward a proactive, data-driven "Precision Animal Health" model. The convergence of veterinary immunology, specialized nutrition, and digital monitoring has redefined the standards of care for both...

  The global landscape of genomic medicine is experiencing unprecedented transformation as the Whole Exome Sequencing Market analysis demonstrates remarkable expansion driven by technological innovations and increasing demand for precision diagnostics. Whole exome sequencing represents a groundbreaking approach that examines all protein-coding regions of genes, comprising...